Clinical Trial Update: Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy [Phase 1]

View source ↗

Summary

Phase 1 trial update for TAK-925 in healthy volunteers and narcolepsy patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• TAK-925

Snippet

Sponsor: Takeda | Conditions: Healthy Participants and Patients With Narcolepsy | Phase 1 | Status: COMPLETED | Results posted: 2020-11-18